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Background

Case History (cont’d)

• Malignancy-associated hypercalcemia (MAHC) occurs in 2030% of cancer patients (1, 2), and is a common cause of
hypercalcemia among hospitalized patients (3).
• Its pathophysiology is generally based on bone metastases or the
production of parathyroid hormone-related peptide (PTHrP) by
tumor cells (4).
• The secreted PTHrP causes hypercalcemia via increased calcium
absorption at the kidney and increased bone resorption.
• Hypercalcemia as the first presentation of malignancy in a
combined hepatocellular carcinoma (HCC) and neuroendocrine
carcinoma (NEC) is extremely rare (5).

• Repeat imaging with liver MRI showed a 17 x 8 cm area of signal
abnormality with 2 more focal anomalies within, suspicious for
malignancy which may be infiltrative. MRI of the thoracolumbar
spine was negative for any metastasis, fractures or lytic lesions.
Skeletal series was also negative for lytic lesions.
• Microscopic evaluation of the CT-guided liver biopsy showed two
distinct patterns. A typical moderately differentiated HCC and a
second malignant focus composed of hyperchromatic small to
intermediate sized cells with apoptosis, atypical mitoses, vaguely
palisading tumor cells around foci of necrosis. This second focus
stained positively with CD56 and CAM 5.2 was suggestive of
neuroendocrine differentiation and epithelial lineage (Refer to
Figures 1-3). Background hepatic parenchyma showed early
cirrhosis likely secondary to long standing hepatitis C or due to
alcohol abuse.
• Tumor
markers
including
alpha-fetoprotein
(AFP),
carcinoembryonic antigen (CEA), and carbohydrate antigen 19-9
(CA 19-9) were all negative. His workup was negative for another
primary malignancy.
• His disease course was complicated by altered mental status and
Klebsiella pneumoniae bacteremia. His PTHrP increased to 335
pg/ml. He received supportive care and expired 3 weeks from
initial presentation.

Aim
• To report on a rare case of combined HCC and NEC presenting
with hypercalcemia.

Case History
• A 67-year-old Caucasian male with a past medical history of
alcohol abuse and previously treated Hepatitis C in 2012 with
ledipasvir/sobosbuvir, was referred to our hospital for evaluation
of hypercalcemia.
• Patient was in his usual state of health until 3 weeks ago when he
started having fatigue, nausea, and anorexia. This was also
associated with impaired memory and confusion.
• He was seen at an outside hospital and was found to have a
calcium of 16.1 mg/dL (normal range 8.5-10.2 mg/dL), so he
was given IV fluids, zoledronic acid and calcitonin with
improvement in calcium to 10.8 mg/dL.
• Computerized tomography (CT) scan of chest/abdomen/pelvis
showed a cirrhotic liver and a 6.5 cm hypodense mass within the
left hepatic lobe. CT scan of thoracolumbar spine was negative
for lytic or blastic lesions with no acute fracture or dislocation.
• Patient was stabilized and transferred to our hospital for
escalation of care.
• Physical examination was remarkable for RUQ tenderness,
hepatomegaly and ascites.
• His calcium level was still elevated at 13 mg/dL.
• His parathyroid hormone (PTH) was low at 8 pg/ml (15-65
pg/ml) and PTHrP was high at 105 pg/ml (14-27 pg/ml).

Figures

Figure 1. Moderately differentiated hepatocellular carcinoma with
admixed high- grade neuroendocrine component (10 X magnification)

Conclusions
• Primary HCC and NEC generally tend to have a poorer prognosis
than conventional HCC.
• To our knowledge, this case is the second report of primary mixed
HCC and NEC associated with MAHC caused by the production of
PTHrP.

Figure 2. High grade component with hyperchromatic nuclei,
abundant apoptotic activity, mitoses and necrosis (40 x magnification)
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Figure 3. CD56 immunoperoxidase staining in high grade
neuroendocrine component (40 x magnification)

